title: Comment on Kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care 2014;37:1076-1082.
authors.affiliation: Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, Amherst, NY.
authors.forename: Sophia
authors.initials: S
authors.lastname: Ali
authors.affiliation: Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, Amherst, NY.
authors.forename: Nitesh
authors.initials: N
authors.lastname: Kuhadiya
authors.affiliation: Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, Amherst, NY.
authors.forename: Husam
authors.initials: H
authors.lastname: Ghanim
authors.affiliation: Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, Amherst, NY pdandona@kaleidahealth.org.
authors.forename: Ajay
authors.initials: A
authors.lastname: Chaudhuri
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D002239:Carbohydrate Metabolism, Inborn Errors / Q000097:blood*; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism*; D005260:Female; D005934:Glucagon / Q000097:blood*; D005947:Glucose / Q000008:administration & dosage*; D005991:Glycerol Kinase / Q000172:deficiency*; D006801:Humans; D008297:Male
chemical_list: D001786:Blood Glucose; D005934:Glucagon; D005991:Glycerol Kinase; D005947:Glucose